fsi-174
Generic: anti-cKIT antibody
fsi-174: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Forty Seven, Inc. (FTSV) | Preclinical |
Get deeper analysis on fsi-174
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis